相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhancement of 26S Proteasome Functionality Connects Oxidative Stress and Vascular Endothelial Inflammatory Response in Diabetes Mellitus
Hongtao Liu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
Mohanraj Rajesh et al.
DIABETES (2012)
Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy
Bing Li et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Angiotensin II Plays a Critical Role in Alcohol-Induced Cardiac Nitrative Damage, Cell Death, Remodeling, and Cardiomyopathy in a Protein Kinase C/Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Dependent Manner
Yi Tan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failure
Harald J. Maier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-κB/TGFβ1 pathway
Yuedong Ma et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Mechanism of the Nrf2/Keap1/ARE signaling system
V. O. Tkachev et al.
BIOCHEMISTRY-MOSCOW (2011)
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Hongting Zheng et al.
DIABETES (2011)
Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome
Zhi-Feng Luo et al.
LIFE SCIENCES (2011)
MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals
Baolin Chen et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Oxidative stress: a key contributor to diabetic cardiomyopathy
Madhu Khullar et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
Proteasome inhibition during myocardial infarction
Xichun Yu et al.
CARDIOVASCULAR RESEARCH (2010)
AMPKα2 Deletion Causes Aberrant Expression and Activation of NAD(P)H Oxidase and Consequent Endothelial Dysfunction In Vivo Role of 26S Proteasomes
Shuangxi Wang et al.
CIRCULATION RESEARCH (2010)
Proteasome Inhibitor MG132 Inhibits Angiogenesis in Pancreatic Cancer by Blocking NF-κB Activity
Yoichi Matsuo et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression
Hua-Qin Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control
Raffaele Marfella et al.
CARDIOVASCULAR PATHOLOGY (2009)
Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection
Henryk Dreger et al.
CARDIOVASCULAR RESEARCH (2009)
Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes
Xiaoqing He et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Cardiac Muscle Protein Catabolism in Diabetes Mellitus: Activation of the Ubiquitin-Proteasome System by Insulin Deficiency
Junping Hu et al.
ENDOCRINOLOGY (2008)
Metallothionein suppresses angiotensin II-Induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart
Guihua Zhou et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Inhibitory kappa B kinase-β is a target for specific nuclear factor kappa B-mediated delayed cardioprotection
Nancy C. Moss et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase-2 expression in human vascular endothelial cells
Sanjeev K. Sahni et al.
THROMBOSIS RESEARCH (2008)
Proteasome-dependent degradation of guanosine 5′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus
Jian Xu et al.
CIRCULATION (2007)
Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy -: The role of angiotensin type 1 receptor antagonism
Dirk Westermann et al.
DIABETES (2007)
Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy
Lu Cai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling
Xiaonan Wang et al.
ENDOCRINOLOGY (2006)
Nontoxic proteasorne inhibition activates a protective antioxidant defense response in endothelial cells
Silke Meiners et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Increasing expression of heme oxygenase-1 by proteasome inhibition protects astrocytes from heme-mediated oxidative injury
J Chen et al.
CURRENT NEUROVASCULAR RESEARCH (2005)
Development of late-stage diabetic nephropathy in OVE26 diabetic mice
SR Zheng et al.
DIABETES (2004)
Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen
NT Marcos et al.
CANCER RESEARCH (2004)
Role of nuclear factor-κB activation in acute ischaemia-reperfusion injury in myocardium
A Kis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
A proteasome inhibitor effectively prevents mouse heart allograft rejection
HY Luo et al.
TRANSPLANTATION (2001)
分享论文
